Tapewire

Nasdaq · USD

AZTA

Azenta, Inc.

Export transactions ↓
Tapewire entity
4724
SEC CIK
0000933974
Parsed reports
596

Last 12 months

Inside the activity.

2 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202610
Jun 202600
Jul 202610
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 22, 2026 Filed Sep 23, 2026 14:24 UTC
Madaus Martin DInterim CEO
Tax withholdingCommon 1,456 $34.28 $49,911.68
Disclosure

SEC source: 0001628280-26-063164 · wk-form4_1790173457.xml · nonDerivative · entry 1

Madaus Martin D · CIK 0001310268 · Interim CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,602

F1 · shares: Shares withheld by the Company to satisfy tax withholding obligations arising from the vesting and settlement on September 22, 2026, of 3,055 restricted stock units held by the Reporting Person. This transaction does not represent a sale of securities by the Reporting Person in the market.

Read SEC document
September 15, 2026 Filed Sep 17, 2026 00:12 UTC
Bello Erik J.VP Chief Accounting Officer
GrantCommon 4,586 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-062341 · wk-form4_1789603974.xml · nonDerivative · entry 1

Bello Erik J. · CIK 0002154435 · VP Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,586

F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. Because the units are payable solely in shares of common stock, they are reported in Table I of this Form 4. The units are subject to time-based vesting and will vest 33-1/3% per year, beginning on September 15, 2027, subject to the terms of the award agreement.

Read SEC document
September 14, 2026 Filed Sep 17, 2026 01:50 UTC
Madaus Martin DInterim CEO
GrantCommon 36,653 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-062354 · wk-form4_1789609812.xml · nonDerivative · entry 1

Madaus Martin D · CIK 0001310268 · Interim CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,058

F1 · shares: Grant of restricted stock units to the Reporting Person under the Company Equity Incentive Plan. No amount was paid upon grant of the units. Because the units are payable solely in shares of common stock, they are reported in Table I of this Form 4. The units are subject to time-based vesting and will vest 1/12 per month for twelve months.

Read SEC document
September 14, 2026 Filed Sep 17, 2026 00:25 UTC
MARTIN WILLIAM E. IIIPresident Multiomics
GrantCommon 15,272 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-062348 · wk-form4_1789604730.xml · nonDerivative · entry 1

MARTIN WILLIAM E. III · CIK 0001949513 · President Multiomics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,062

F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. Because the units are payable solely in shares of common stock, they are reported in Table I of this Form 4. The units are subject to time-based vesting and will vest 50% per year, beginning on September 14, 2027, subject to the terms of the award agreement.

Read SEC document
September 14, 2026 Filed Sep 17, 2026 00:21 UTC
Pirogova OlgaSVP and CHRO
GrantCommon 15,272 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-062345 · wk-form4_1789604464.xml · nonDerivative · entry 1

Pirogova Olga · CIK 0002000496 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,225

F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. Because the units are payable solely in shares of common stock, they are reported in Table I of this Form 4. The units are subject to time-based vesting and will vest 50% per year, beginning on September 14, 2027, subject to the terms of the award agreement.

Read SEC document
September 14, 2026 Filed Sep 17, 2026 00:19 UTC
Lin Lawrence Y.EVP, CFO and Treasurer
GrantCommon 30,544 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-062344 · wk-form4_1789604338.xml · nonDerivative · entry 1

Lin Lawrence Y. · CIK 0002045844 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,199

F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. Because the units are payable solely in shares of common stock, they are reported in Table I of this Form 4. The units are subject to time-based vesting and will vest 50% per year, beginning on September 14, 2027, subject to the terms of the award agreement.

Read SEC document
September 14, 2026 Filed Sep 17, 2026 00:16 UTC
Starr EphraimSVP, Gen Counsel & Secretary
GrantCommon 15,272 $0.00 $0.00
Disclosure

SEC source: 0001628280-26-062343 · wk-form4_1789604158.xml · nonDerivative · entry 1

Starr Ephraim · CIK 0002069816 · SVP, Gen Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,000

F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. Because the units are payable solely in shares of common stock, they are reported in Table I of this Form 4. The units are subject to time-based vesting and will vest 50% per year, beginning on September 14, 2027, subject to the terms of the award agreement.

Read SEC document
August 09, 2026 Filed Aug 11, 2026 20:41 UTC
Pirogova OlgaSVP and CHRO
Tax withholdingCommon 1,085 $32.04 $34,763.40
Disclosure

SEC source: 0001628280-26-055760 · wk-form4_1786480883.xml · nonDerivative · entry 1

Pirogova Olga · CIK 0002000496 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,953

F1 · shares: Shares withheld by the Company to satisfy tax withholding obligations arising upon the vesting on August 9, 2026. This transaction does not represent a sale of securities by the Reporting Person in the market.

Read SEC document
July 31, 2026 Filed Aug 4, 2026 22:11 UTC
Starr EphraimSVP, Gen Counsel & Secretary
PurchaseCommon 335 $24.17 $8,096.15
Disclosure

SEC source: 0001628280-26-052799 · wk-form4_1785881503.xml · nonDerivative · entry 1

Starr Ephraim · CIK 0002069816 · SVP, Gen Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,728

F1 · shares: Purchase by the Reporting Person under the Azenta, Inc. 2017 Employee Stock Purchase Plan. The purchase of shares was exempt from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3(c) thereunder.

Read SEC document
May 18, 2026 Filed May 19, 2026 20:10 UTC PurchaseCommon 10,000 $16.38 $163,800.00
Disclosure

SEC source: 0001193125-26-230764 · ownership.xml · nonDerivative · entry 1

Cornog William L · CIK 0001697415 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 19,703

F1 · price: Represents the weighted average price for the shares purchased. The shares were purchased at per-share prices ranging from $16.19 to $16.52. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.

F2 · ownership.nature: Reflects shares held in trusts beneficially owned by the reporting person, of which the reporting person, his spouse and children are beneficiaries, and as to which the reporting person is the trustee and has investment and voting power.

Read SEC document
May 15, 2026 Filed May 18, 2026 20:10 UTC
Starr EphraimSVP, Gen Counsel & Secretary
Tax withholdingCommon 3,621 $16.02 $58,008.42
Disclosure

SEC source: 0002069816-26-000002 · ownership.xml · nonDerivative · entry 1

Starr Ephraim · CIK 0002069816 · SVP, Gen Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,393

F1 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on May 15, 2026 of 12,593 restricted stock units held by the reporting person.

Read SEC document
April 28, 2026 Filed Apr 30, 2026 20:15 UTC
MARTIN WILLIAM E. IIIPresident Multiomics
GrantCommon 17,790 $24.24 $431,229.60
Disclosure

SEC source: 0001949513-26-000008 · ownership.xml · nonDerivative · entry 1

MARTIN WILLIAM E. III · CIK 0001949513 · President Multiomics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,790

F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. The units will vest over three years, 33% on Apriil 18, 2027, 33% on Apriil 18, 2028, and 33% on Apriil 18, 2029.

Read SEC document
February 06, 2026 Filed Feb 6, 2026 23:12 UTC GrantCommon 5,663 $27.85 $157,714.55
Disclosure

SEC source: 0001193125-26-041527 · ownership.xml · nonDerivative · entry 1

Nova Tina Susan · CIK 0001302605 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,772

F1 · shares: Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares.

Read SEC document
February 05, 2026 Filed Feb 6, 2026 22:47 UTC GrantRestricted Stock Unit · Derivative 5,663 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001193125-26-041487 · ownership.xml · derivative · entry 1

Cornog William L · CIK 0001697415 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,663

Underlying: Common Stock · 5,663 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company.

F2 · price: Grant of Restricted Stock Units under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the units.

F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company.

F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company.

Read SEC document
February 05, 2026 Filed Feb 6, 2026 22:47 UTC GrantRestricted Stock Unit · Derivative 5,663 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001193125-26-041485 · ownership.xml · derivative · entry 1

Madaus Martin D · CIK 0001310268 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,703

Underlying: Common Stock · 5,663 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company.

F2 · price: Grant of Restricted Stock Units under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the units.

F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company.

F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company.

Read SEC document
February 05, 2026 Filed Feb 6, 2026 22:46 UTC
Doshi DipalDirector
GrantCommon 5,663 $27.85 $157,714.55
Disclosure

SEC source: 0001193125-26-041482 · ownership.xml · nonDerivative · entry 1

Doshi Dipal · CIK 0001613084 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,703

F1 · shares: Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares.

Read SEC document
February 05, 2026 Filed Feb 6, 2026 22:45 UTC
Casal FrankDirector
GrantCommon 7,243 $27.85 $201,717.55
Disclosure

SEC source: 0001193125-26-041478 · ownership.xml · nonDerivative · entry 1

Casal Frank · CIK 0001891819 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,803

F1 · shares: Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares.

Read SEC document
February 05, 2026 Filed Feb 6, 2026 22:44 UTC GrantCommon 5,663 $27.85 $157,714.55
Disclosure

SEC source: 0001193125-26-041476 · ownership.xml · nonDerivative · entry 1

McLaughlin Erica · CIK 0001740348 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,521

F1 · shares: Grant of unrestricted shares under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the shares.

Read SEC document
February 05, 2026 Filed Feb 6, 2026 22:43 UTC GrantRestricted Stock Unit · Derivative 5,663 Not disclosed Strike: $0.00 Not disclosed
Disclosure

SEC source: 0001193125-26-041473 · ownership.xml · derivative · entry 1

Davis Robyn C · CIK 0001580601 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,662

Underlying: Common Stock · 5,663 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company.

F2 · price: Grant of Restricted Stock Units under the Company's 2020 Equity Incentive Plan. No amount was paid upon grant of the units.

F1 · derivative.exercise_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company.

F1 · derivative.expiration_date: Each restricted stock unit represents the right to receive one share of Azenta's common stock. The units are fully vested upon grant but the Reporting Person elected to have the settlement deferred until the later of his attainment of age 65 or his separation from service from the company.

Read SEC document
February 05, 2026 Filed May 12, 2026 20:01 UTC GrantCommon Stock 5,663 $0.00 $0.00
Disclosure

SEC source: 0001104659-26-059359 · tm2614389-1_4seq1.xml · nonDerivative · entry 1

Koffey Quentin · CIK 0001984174 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,698

F1 · shares: Annual grant of unrestricted shares under the Issuer's 2020 Equity Incentive Plan in connection with the Reporting Person's service on the Issuer's Board of Directors (the "Board"). The number of shares was determined based on an annual grant amount of $215,000 and a price per share of $37.97 based on the average daily closing price for the 20 trading-day period immediately preceding and including February 5, 2026.

F2 · price: No amount was paid upon grant of the shares.

Read SEC document
November 24, 2025 Filed Nov 26, 2025 01:23 UTC
Lin Lawrence Y.EVP, CFO and Treasurer
GrantCommon 36,681 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-297842 · ownership.xml · nonDerivative · entry 1

Lin Lawrence Y. · CIK 0002045844 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,655

F1 · shares: Represents the grant of restricted stock units ("RSUs"). No amount was paid upon grant of the RSUs. The number of RSUs granted was determined by dividing the target award value by the average closing price of the Company's common stock over the 20 trading days ending on the date of grant. The RSUs are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 24, 2026.

Read SEC document
November 24, 2025 Filed Nov 26, 2025 01:26 UTC
Marotta JohnDirector · President and CEO
GrantCommon 122,269 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-297847 · ownership.xml · nonDerivative · entry 1

Marotta John · CIK 0001882058 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 217,268.78

F1 · shares: Represents the grant of restricted stock units ("RSUs"). No amount was paid upon grant of the RSUs. The number of RSUs granted was determined by dividing the target award value by the average closing price of the Company's common stock over the 20 trading days ending on the date of grant. The RSUs are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 24, 2026.

Read SEC document
November 24, 2025 Filed Nov 26, 2025 01:20 UTC
Pirogova OlgaSVP and CHRO
GrantCommon 16,303 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-297837 · ownership.xml · nonDerivative · entry 1

Pirogova Olga · CIK 0002000496 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,038

F1 · shares: Represents the grant of restricted stock units ("RSUs"). No amount was paid upon grant of the RSUs. The number of RSUs granted was determined by dividing the target award value by the average closing price of the Company's common stock over the 20 trading days ending on the date of grant. The RSUs are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 24, 2026.

Read SEC document
November 24, 2025 Filed Nov 26, 2025 01:11 UTC
Starr EphraimSVP, Gen Counsel & Secretary
GrantCommon 34,235 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-297823 · ownership.xml · nonDerivative · entry 1

Starr Ephraim · CIK 0002069816 · SVP, Gen Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,014

F1 · shares: Represents the grant of restricted stock units ("RSUs"). No amount was paid upon grant of the RSUs. The number of RSUs granted was determined by dividing the target award value by the average closing price of the Company's common stock over the 20 trading days ending on the date of grant. The RSUs are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 24, 2026.

Read SEC document
November 24, 2025 Filed Nov 26, 2025 01:15 UTC
Zhou GingerSVP and GM, Multiomics
GrantCommon 13,042 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-297830 · ownership.xml · nonDerivative · entry 1

Zhou Ginger · CIK 0001953934 · SVP and GM, Multiomics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,755

F1 · shares: Represents the grant of restricted stock units ("RSUs"). No amount was paid upon grant of the RSUs. The number of RSUs granted was determined by dividing the target award value by the average closing price of the Company's common stock over the 20 trading days ending on the date of grant. The RSUs are subject to time-based vesting and will vest 33-1/3% per year, beginning on November 24, 2026.

Read SEC document
November 24, 2025 Filed Dec 3, 2025 23:29 UTC Amendment
Marotta JohnDirector · President and CEO
GrantCommon 118,194 $0.00 $0.00
Disclosure

SEC source: 0001193125-25-307099 · ownership.xml · nonDerivative · entry 1

Marotta John · CIK 0001882058 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 213,193.78

F1 · shares: This amendment to Form 4 is being filed to correct the number of restricted stock units ("RSUs") previously reported. The original Form 4 filed on November 25, 2025 incorrectly stated that 122,269 RSUs were acquired. The correct number is 118,194 RSUs. As a result of this correction, the total number of securities beneficially owned following the reported transaction has also been revised to 213,193.78. All other information in the original Form 4 remains unchanged.

F1 · balance_after: This amendment to Form 4 is being filed to correct the number of restricted stock units ("RSUs") previously reported. The original Form 4 filed on November 25, 2025 incorrectly stated that 122,269 RSUs were acquired. The correct number is 118,194 RSUs. As a result of this correction, the total number of securities beneficially owned following the reported transaction has also been revised to 213,193.78. All other information in the original Form 4 remains unchanged.

Read SEC document
November 14, 2025 Filed Nov 17, 2025 21:54 UTC
Zhou GingerSVP and GM, Multiomics
Tax withholdingCommon 1,118 $29.75 $33,260.50
Disclosure

SEC source: 0001193125-25-284747 · ownership.xml · nonDerivative · entry 1

Zhou Ginger · CIK 0001953934 · SVP and GM, Multiomics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,713

F1 · shares: The withholding of shares from the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2025 of 4,582 restricted stock units held by the reporting person.

Read SEC document
November 14, 2025 Filed Nov 17, 2025 21:52 UTC
Pirogova OlgaSVP and CHRO
Tax withholdingCommon 1,553 $29.75 $46,201.75
Disclosure

SEC source: 0001193125-25-284743 · ownership.xml · nonDerivative · entry 1

Pirogova Olga · CIK 0002000496 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,735

F1 · shares: The withholding of shares from the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2025 of 4,529 restricted stock units held by the reporting person.

Read SEC document
November 14, 2025 Filed Nov 17, 2025 21:48 UTC
Lin Lawrence Y.EVP, CFO and Treasurer
Tax withholdingCommon 3,039 $29.75 $90,410.25
Disclosure

SEC source: 0001193125-25-284737 · ownership.xml · nonDerivative · entry 1

Lin Lawrence Y. · CIK 0002045844 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,974

F1 · shares: The withholding of shares from the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2025 of 10,566 restricted stock units held by the reporting person.

Read SEC document
November 14, 2025 Filed Nov 17, 2025 21:45 UTC
Marotta JohnDirector · President and CEO
Tax withholdingCommon 10,980 $29.75 $326,655.00
Disclosure

SEC source: 0001193125-25-284729 · ownership.xml · nonDerivative · entry 1

Marotta John · CIK 0001882058 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,999.78

F1 · shares: The withholding of shares from the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on November 15, 2025 of 27,872 restricted stock units held by the reporting person.

Read SEC document
September 10, 2025 Filed Sep 12, 2025 20:10 UTC
Marotta JohnDirector · President and CEO
SaleCommon 316 $29.41 $9,293.56
Disclosure

SEC source: 0000950170-25-114528 · ownership.xml · nonDerivative · entry 1

Marotta John · CIK 0001882058 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 105,979.78

F1 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on September 9, 2025 of 1,091 restricted stock units held by the reporting person.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 20:44 UTC
Pirogova OlgaSVP and CHRO
Disposition to issuerCommon 1,085 $28.54 $30,965.90
Disclosure

SEC source: 0000950170-25-108106 · ownership.xml · nonDerivative · entry 1

Pirogova Olga · CIK 0002000496 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,288

F1 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on August 9, 2025 of 3,167 restricted stock units held by the reporting person.

Read SEC document
August 12, 2025 Filed Aug 13, 2025 20:47 UTC
Zhou GingerSVP and GM, Multiomics
Disposition to issuerCommon 1,085 $28.54 $30,965.90
Disclosure

SEC source: 0000950170-25-108118 · ownership.xml · nonDerivative · entry 1

Zhou Ginger · CIK 0001953934 · SVP and GM, Multiomics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,831

F1 · shares: The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on August 9, 2025 of 3,167 restricted stock units held by the reporting person.

Read SEC document
August 12, 2025 Filed Nov 14, 2025 21:10 UTC Amendment
Pirogova OlgaSVP and CHRO
SaleCommon 1,085 $28.54 $30,965.90
Disclosure

SEC source: 0001193125-25-282948 · ownership.xml · nonDerivative · entry 1

Pirogova Olga · CIK 0002000496 · SVP and CHRO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,288

F1 · date: This amendment is being filed to include the Power of Attorney authorizing the undersigned to sign and file Forms 3, 4, and 5 on behalf of the reporting person, which was inadvertently not included with the original Form 4 filed on August 13, 2025.

F2 · kind: This amendment is being filed to correct an administrative error in the transaction code reported in the original Form 4 filed on August 13, 2025. The transaction was inadvertently reported using transaction code "D" instead of the correct code "S."

Read SEC document
August 12, 2025 Filed Nov 14, 2025 21:10 UTC Amendment
Zhou GingerSVP and GM, Multiomics
SaleCommon 1,085 $28.54 $30,965.90
Disclosure

SEC source: 0001193125-25-282944 · ownership.xml · nonDerivative · entry 1

Zhou Ginger · CIK 0001953934 · SVP and GM, Multiomics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,831

F1 · date: This amendment is being filed to include the Power of Attorney authorizing the undersigned to sign and file Forms 3, 4, and 5 on behalf of the reporting person, which was inadvertently not included with the original Form 4 filed on August 13, 2025.

F2 · kind: This amendment is being filed to correct an administrative error in the transaction code reported in the original Form 4 filed on August 13, 2025. The transaction was inadvertently reported using transaction code "D" instead of the correct code "S."

Read SEC document
August 11, 2025 Filed Aug 12, 2025 20:05 UTC
Lin Lawrence Y.EVP, CFO and Treasurer
PurchaseCommon 2,500 $27.96 $69,900.00
Disclosure

SEC source: 0000950170-25-107291 · ownership.xml · nonDerivative · entry 1

Lin Lawrence Y. · CIK 0002045844 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46,013

F1 · shares: Open market purchase.

Read SEC document
June 02, 2025 Filed Jun 4, 2025 20:30 UTC
Marotta JohnDirector · President and CEO
GrantCommon 1,000 $25.99 $25,990.00
Disclosure

SEC source: 0000950170-25-081659 · ownership.xml · nonDerivative · entry 1

Marotta John · CIK 0001882058 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,295.78

F1 · shares: Open market purchase.

Read SEC document
June 02, 2025 Filed Nov 14, 2025 21:10 UTC Amendment
Marotta JohnDirector · President and CEO
PurchaseCommon 1,000 $25.99 $25,990.00
Disclosure

SEC source: 0001193125-25-282947 · ownership.xml · nonDerivative · entry 1

Marotta John · CIK 0001882058 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,295.78

F1 · date: This amendment is being filed to include the Power of Attorney authorizing the undersigned to sign and file Forms 3, 4, and 5 on behalf of the reporting person, which was inadvertently not included with the original Form 4 filed on June 4, 2025.

F2 · kind: This amendment is being filed to correct an administrative error in the transaction code reported in the original Form 4 filed on June 4, 2025. The transaction was inadvertently reported using transaction code "A" instead of the correct code "P."

Read SEC document
May 30, 2025 Filed Jun 3, 2025 20:10 UTC
Malus Alan JDirector
GrantCommon 12,000 $26.65 $319,800.00
Disclosure

SEC source: 0000950170-25-080924 · ownership.xml · nonDerivative · entry 1

Malus Alan J · CIK 0001380163 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,035

F1 · shares: Open market purchase.

Read SEC document
May 30, 2025 Filed Nov 14, 2025 21:10 UTC Amendment
Malus Alan JDirector
PurchaseCommon 12,000 $26.65 $319,800.00
Disclosure

SEC source: 0001193125-25-282946 · ownership.xml · nonDerivative · entry 1

Malus Alan J · CIK 0001380163 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,035

F1 · date: This amendment is being filed to include the Power of Attorney authorizing the undersigned to sign and file Forms 3, 4, and 5 on behalf of the reporting person, which was inadvertently not included with the original Form 4 filed on June 3, 2025.

F2 · kind: This amendment is being filed to correct an administrative error in the transaction code reported in the original Form 4 filed on June 3, 2025. The transaction was inadvertently reported using transaction code "A" instead of the correct code "P."

Read SEC document
May 20, 2025 Filed May 20, 2025 20:07 UTC GrantCommon 2,748 $27.37 $75,212.76
Disclosure

SEC source: 0000950170-25-075180 · ownership.xml · nonDerivative · entry 3

Cornog William L · CIK 0001697415 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 21,755

F3 · price: Represents the weighted average price for the shares purchased. The shares were purchased at per-share prices ranging from $27.16 to $27.49. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.

F1 · ownership.nature: Reflects shares held in trusts beneficially owned by the reporting person, of which the reporting person, his spouse and children are beneficiaries, and as to which the reporting person is the trustee and has investment and voting power.

Read SEC document
May 20, 2025 Filed Nov 25, 2025 21:28 UTC Amendment PurchaseCommon 2,748 $27.37 $75,212.76
Disclosure

SEC source: 0001193125-25-297311 · ownership.xml · nonDerivative · entry 3

Cornog William L · CIK 0001697415 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,795

F1 · kind: This amendment is being filed to correct an administrative error in the transaction code reported in the original Form 4 filed on May 20,, 2025. The transaction was inadvertently reported using transaction code "A" instead of the correct code "P."

F4 · balance_after: The original Form 4, filed on May 20, 2025, is being amended by this Form 4 Amendment to correct an administrative error which miscalculated the amount of 21,755 beneficially owned shares after the purchase of 2,748 shares when in fact the correct number of beneficially owned shares was 25,795. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned.

Read SEC document
May 19, 2025 Filed May 20, 2025 20:07 UTC GrantCommon 4,152 $26.98 $112,020.96
Disclosure

SEC source: 0000950170-25-075180 · ownership.xml · nonDerivative · entry 2

Cornog William L · CIK 0001697415 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 19,007

F2 · price: Represents the weighted average price for the shares purchased. The shares were purchased at per-share prices ranging from $26.75 to $27.00. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.

F1 · ownership.nature: Reflects shares held in trusts beneficially owned by the reporting person, of which the reporting person, his spouse and children are beneficiaries, and as to which the reporting person is the trustee and has investment and voting power.

Read SEC document
May 19, 2025 Filed Nov 25, 2025 21:28 UTC Amendment PurchaseCommon 4,152 $26.98 $112,020.96
Disclosure

SEC source: 0001193125-25-297311 · ownership.xml · nonDerivative · entry 2

Cornog William L · CIK 0001697415 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,047

F1 · kind: This amendment is being filed to correct an administrative error in the transaction code reported in the original Form 4 filed on May 20,, 2025. The transaction was inadvertently reported using transaction code "A" instead of the correct code "P."

F3 · balance_after: The original Form 4, filed on May 20, 2025, is being amended by this Form 4 Amendment to correct an administrative error which miscalculated the amount of 19,007 beneficially owned shares after the purchase of 4,152 shares when in fact the correct number of beneficially owned shares was 23,047. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned.

Read SEC document
May 16, 2025 Filed May 20, 2025 20:07 UTC GrantCommon 100 $26.50 $2,650.00
Disclosure

SEC source: 0000950170-25-075180 · ownership.xml · nonDerivative · entry 1

Cornog William L · CIK 0001697415 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 14,855

F1 · ownership.nature: Reflects shares held in trusts beneficially owned by the reporting person, of which the reporting person, his spouse and children are beneficiaries, and as to which the reporting person is the trustee and has investment and voting power.

Read SEC document
May 16, 2025 Filed Nov 25, 2025 21:28 UTC Amendment PurchaseCommon 100 $26.50 $2,650.00
Disclosure

SEC source: 0001193125-25-297311 · ownership.xml · nonDerivative · entry 1

Cornog William L · CIK 0001697415 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,895

F1 · kind: This amendment is being filed to correct an administrative error in the transaction code reported in the original Form 4 filed on May 20,, 2025. The transaction was inadvertently reported using transaction code "A" instead of the correct code "P."

F2 · balance_after: The original Form 4, filed on May 20, 2025, is being amended by this Form 4 Amendment to correct an administrative error which miscalculated the amount of 14,855 beneficially owned shares after the purchase of 100 shares when in fact the correct number of beneficially owned shares was 18,895. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned.

Read SEC document
May 15, 2025 Filed May 27, 2025 22:30 UTC
Starr EphraimSVP, Gen Counsel & Secretary
GrantCommon 37,779 $26.71 $1,009,077.09
Disclosure

SEC source: 0000950170-25-077926 · ownership.xml · nonDerivative · entry 1

Starr Ephraim · CIK 0002069816 · SVP, Gen Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,779

F1 · shares: Grant of restricted stock units to the Reporting Person under the Company's Equity Incentive Plan. No amount was paid upon grant of the units. The units will vest over three years, 33% on May 15, 2026, 33% on May 15, 2027, and 33% on May 15, 2028.

Read SEC document
May 09, 2025 Filed May 12, 2025 20:05 UTC
Lin Lawrence Y.EVP, CFO and Treasurer
GrantCommon 4,000 $27.49 $109,960.00
Disclosure

SEC source: 0000950170-25-069158 · ownership.xml · nonDerivative · entry 2

Lin Lawrence Y. · CIK 0002045844 · EVP, CFO and Treasurer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,513

F1 · shares: Open market purchase.

F2 · price: Represents the weighted average price for the shares purchased. The shares were purchased at per-share prices ranging from $27.37 to $27.70. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
May 09, 2025 Filed May 12, 2025 20:05 UTC
Marotta JohnDirector · President and CEO
GrantCommon 1,796.165 $27.84 $50,005.23
Disclosure

SEC source: 0000950170-25-069157 · ownership.xml · nonDerivative · entry 2

Marotta John · CIK 0001882058 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,295.78

F1 · shares: Open market purchase.

F3 · price: Represents the weighted average price for the shares purchased on May 9, 2025. The shares were purchased at per-share prices ranging from $27.39 to $27.84. The reporting person will provide to the SEC, the issuer and any stockholder, upon request, full information regarding the number of shares purchased or sold at each separate price.

Read SEC document
May 09, 2025 Filed Jun 4, 2025 20:10 UTC Amendment
Marotta JohnDirector · President and CEO
GrantCommon 1,796.165 $27.49 $49,376.58
Disclosure

SEC source: 0000950170-25-081626 · ownership.xml · nonDerivative · entry 2

Marotta John · CIK 0001882058 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,295.78

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.